158 related articles for article (PubMed ID: 21787115)
1. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
3. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
4. Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk.
Einarsdóttir K; Humphreys K; Bonnard C; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Hum Mol Genet; 2007 Jan; 16(2):154-64. PubMed ID: 17164260
[TBL] [Abstract][Full Text] [Related]
5. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C; Damiola F; Moissonnier M; Durand G; Malakhova I; Masyakin V; Le Calvez-Kelm F; Cardis E; Byrnes G; Kesminiene A; Lesueur F
BMC Cancer; 2017 May; 17(1):328. PubMed ID: 28499365
[TBL] [Abstract][Full Text] [Related]
6. SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Kuroiwa-Trzmielina J; Wang F; Rapkins RW; Ward RL; Buchanan DD; Win AK; Clendenning M; Rosty C; Southey MC; Winship IM; Hopper JL; Jenkins MA; Olivier J; Hawkins NJ; Hitchins MP
Clin Cancer Res; 2016 Dec; 22(24):6266-6277. PubMed ID: 27267851
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor gene variants and risk of endometrial cancer.
O'Mara TA; Fahey P; Ferguson K; Marquart L; Lambrechts D; Despierre E; Vergote I; Amant F; Hall P; Liu J; Czene K; ; Rebbeck TR; ; ; ; Ahmed S; Dunning AM; Gregory CS; Shah M; ; Webb PM; Spurdle AB
Carcinogenesis; 2011 Mar; 32(3):331-5. PubMed ID: 21148628
[TBL] [Abstract][Full Text] [Related]
8. Lack of influence of MGMT codon Leu84Phe and codon Ileu143Val polymorphisms on esophageal cancer risk in the Kashmir Valley.
Shah MA; Shaff SM; Lone GN; Jan SM
Asian Pac J Cancer Prev; 2012; 13(7):3047-52. PubMed ID: 22994708
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma.
Doecke J; Zhao ZZ; Pandeya N; Sadeghi S; Stark M; Green AC; Hayward NK; Webb PM; Whiteman DC;
Int J Cancer; 2008 Jul; 123(1):174-80. PubMed ID: 18386788
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in MGMT and risk of lung cancer in Southeastern Chinese: a haplotype-based analysis.
Hu Z; Wang H; Shao M; Jin G; Sun W; Wang Y; Liu H; Wang Y; Ma H; Qian J; Jin L; Wei Q; Lu D; Huang W; Shen H
Hum Mutat; 2007 May; 28(5):431-40. PubMed ID: 17285603
[TBL] [Abstract][Full Text] [Related]
11. Germline Variants in DNA Repair Genes, Diagnostic Radiation, and Risk of Thyroid Cancer.
Sandler JE; Huang H; Zhao N; Wu W; Liu F; Ma S; Udelsman R; Zhang Y
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):285-294. PubMed ID: 29263185
[No Abstract] [Full Text] [Related]
12. The role of MGMT polymorphisms rs12917 and rs11016879 in head and neck cancer risk and prognosis.
Kiczmer P; Prawdzic Seńkowska A; Strzelczyk JK; Szydło B; Biernacki K; Osadnik T; Krakowczyk Ł; Ostrowska Z
Acta Biochim Pol; 2018; 65(1):87-92. PubMed ID: 29370316
[TBL] [Abstract][Full Text] [Related]
13. Endometrial vezatin and its association with endometriosis risk.
Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
[TBL] [Abstract][Full Text] [Related]
14. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer.
Zhang Z; Wang L; Wei S; Liu Z; Wang LE; Sturgis EM; Wei Q
DNA Repair (Amst); 2010 May; 9(5):558-66. PubMed ID: 20206583
[TBL] [Abstract][Full Text] [Related]
16. Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.
Gu H; Qiu W; Wan Y; Ding G; Tang W; Liu C; Shi Y; Chen Y; Chen S
Mol Biol Rep; 2012 May; 39(5):5977-84. PubMed ID: 22201027
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.
Forma E; Wójcik-Krowiranda K; Jóźwiak P; Szymczyk A; Bieńkiewicz A; Bryś M; Krześlak A
Pathol Oncol Res; 2014 Jul; 20(3):597-602. PubMed ID: 24346708
[TBL] [Abstract][Full Text] [Related]
18. Association and interactions between DNA repair gene polymorphisms and adult glioma.
Liu Y; Scheurer ME; El-Zein R; Cao Y; Do KA; Gilbert M; Aldape KD; Wei Q; Etzel C; Bondy ML
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):204-14. PubMed ID: 19124499
[TBL] [Abstract][Full Text] [Related]
19. The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide.
Rapkins RW; Wang F; Nguyen HN; Cloughesy TF; Lai A; Ha W; Nowak AK; Hitchins MP; McDonald KL
Neuro Oncol; 2015 Dec; 17(12):1589-98. PubMed ID: 25910840
[TBL] [Abstract][Full Text] [Related]
20. Inherited predisposition of lung cancer: a hierarchical modeling approach to DNA repair and cell cycle control pathways.
Hung RJ; Baragatti M; Thomas D; McKay J; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Moullan N; Canzian F; Hall J; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2736-44. PubMed ID: 18086781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
